![Loading Events](https://www.researchamerica.org/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
- This event has passed.
Alliance Discussion: Finding New Hope in Existing Drugs: a conversation with ARPA-H Project Awardee Dr. David Fajgenbaum, Co-Founder & President of Every Cure
June 13 @ 11:00 am - 11:45 am
![](https://www.researchamerica.org/wp-content/uploads/2024/04/David-Fajgenbaum.jpeg)
Globally, there are millions of people diagnosed with diseases that have no available or approved treatments. Drug repurposing or using an approved drug as a new treatment for another disease has been an effective, but underutilized tool in therapeutic discovery. In February 2024, Every Cure received an ARPA-H Project Award to develop an AI-powered platform, called ML/AI-enabled Therapeutic Repurposing In eXtended uses (MATRIX). Co-Founder & President of Every Cure, Dr. David Fajgenbaum, joined us to share how he repurposed an existing drug to save his life and now is on a mission to unlock treatments for millions more using the power of AI.